Tiered Copays: Why Your Generic Drug Might Cost More Than Expected
Your generic drug might cost more than the brand name because of how insurers tier medications. It’s not about quality - it’s about rebates. Here’s why and what to do about it.
Your generic drug might cost more than the brand name because of how insurers tier medications. It’s not about quality - it’s about rebates. Here’s why and what to do about it.
Medicare is now negotiating drug prices for the first time, cutting costs by up to 79% on 10 top medications starting in 2026. Here's how it works, who it helps, and what's coming next.
Generic drugs saved $482 billion in the U.S. in 2024 alone, making them the most powerful tool to control rising drug costs. Learn how generics and biosimilars cut spending, why brand drugs remain expensive, and what’s blocking even bigger savings.
Theophylline has a narrow therapeutic window where too little fails and too much kills. Regular blood monitoring is essential to avoid toxicity and ensure effectiveness in asthma and COPD treatment.
Deprescribing safely reduces unnecessary medications to cut side effects, especially in older adults. Learn how frameworks like Shed-MEDS and STOPP/START help doctors and pharmacists cut pill burden without risking health.
Tentative approval from the FDA means a generic drug is scientifically ready - but legal, manufacturing, or market barriers often prevent it from ever reaching patients. Here’s why delays happen and who’s affected.
The first trimester is the most critical time for fetal development. Learn which medications are safe, which to avoid, and how to make informed choices during pregnancy with evidence-based guidance.
Most people who think they're allergic to medications are actually experiencing side effects. Learn how to tell the difference, why it matters for your treatment, and what steps to take if you've been mislabeled.
Learn exactly what the FDA requires for stability testing of generic drugs, from batch sizes and storage conditions to common reasons for rejection and how manufacturers are adapting to stricter rules.
Ezetimibe and bempedoic acid offer proven, non-statin options for lowering LDL cholesterol in people who can't tolerate statins. Both reduce heart risk, with ezetimibe being affordable and bempedoic acid offering proven cardiovascular benefits.
The FDA and EMA often approve the same drugs but with different labels due to contrasting legal frameworks, risk tolerance, and patient communication styles. These differences impact access, safety, and costs worldwide.
UK NHS substitution laws now require pharmacies to use generic medicines by default and shift care from hospitals to community settings. Learn how these 2025 changes affect prescriptions, access, and safety - and what you can do about it.